A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier applauds FDA for addressing the inequities that exists for individuals who identify as LGBTQ+ and their eligibility to donate blood.
Premier provides input on the Administration's proposal to modernize the 40-year-old law governing providers' access to their patients' data on substance use.
As the 118th Congress commences, government leaders have an opportunity to coalesce around meaningful healthcare policy solutions.
Take Premier's brief survey on what waivers are still being leveraged and the readiness of providers to unwind from the COVID-19 public health emergency.
Watch this on-demand webinar to learn more about these proposed regulatory changes and how they could impact your organization.
Discover how to use actionable data and insights to increase visibility and decrease product shortages in today's fragile supply chain environment.
The American Journal of Managed Care® | In abstracts at ASH 2022, investigators detailed patient and financial outcomes associated with CAR T-cell therapies vs standard of care for treatment of large B-cell lymphoma.
SKU-level data that helps life sciences and medical device organizations address RWD/RWE needs to support research, solution development and regulatory requirements.
An equity-centered, design-thinking approach is helping health systems, life sciences, community and patient organizations co-design solutions to reduce health disparities.
Healthcare Brew | Many struggling women fall through the cracks due to payment issues, lack of care coordination.
Premier responds to healthcare provisions in the FY 2023 omnibus funding package released by Congress.
Premier urges FDA . Premier urges the FDA to address three critical areas to ensure success in reducing disparities for medical devices.